Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from Vaccine

Oxford University and Moderna launch trials of vaccine that could prevent cancer

The jab targets patients with Lynch syndrome, who are at high risk of colorectal and ovarian cancer

The Independent UK

The hunt for a new Ebola vaccine: two scientists explain the challenges

The ongoing Ebola virus outbreak in the Democratic Republic of Congo (DRC) and Uganda has now killed 61 people, with 359 confirmed cases. The Bundibugyo strain of the virus has a fatality rate of between 30% and 50%, and there is currently no vaccine approved for it. Two scientists at…

The Conversation

Breakthrough in Vaccine Science: AI-Designed Universal Coronavirus Shot Shows Safety in First Human Trial

AI-designed universal coronavirus vaccine shows safety and immune response in first human trial, targeting multiple coronaviruses including SARS and MERS.

Medical Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

FED:Dangerous winter virus far more than 'just a bad cold'

Health authorities are urging seniors to get a free vaccine to protect them from a common winter virus that can cause severe illness, hospitalisation and death.

AAP

Dangerous winter virus far more than 'just a bad cold'

Health authorities are urging seniors to get a free vaccine to protect them from a common winter virus that can cause severe illness, hospitalisation and death.

AAP

Today Is National Cancer Survivors Day — Half a Million Survivors Living in New York City Signal a Powerful Story of Hope and Progress

National Cancer Survivors Day 2026 highlights 500,000 NYC survivors and major research breakthroughs, including mRNA cancer vaccines, rising survival rates.

Medical Daily

US insurers’ move to back vaccines sends ‘powerful’ message about safety of shots, experts say

As Trump officials take aim at vaccine schedule, scientists encouraged by companies’ desire to continue coverage

The Guardian - US

Read news from The Economist, FT, and more,
with one subscription

Australia’s winter illness season is back – what viruses are prevalent this year and when should you get vaccinated?

Comparatively low numbers of respiratory viruses so far this year follows the worst influenza season in Australia on record in 2025, which saw more than 500,000 confirmed infections

The Guardian - AU

‘This is a fundamental shift in how we prepare for pandemics’: Researchers used AI and known genetic codes to develop a ‘fundamentally new’ vaccine that ‘could help speed up the roll out vaccines to benefit people all over the world’

The research team hope that the new AI development method could help create vaccines that target a whole family of viruses

TechRadar

First AI-designed 'universal vaccine' tested in humans: UK researchers

A groundbreaking vaccine, designed entirely by artificial intelligence, has been tested in humans for the first time. This experimental jab aims to protect against a wide range of viruses, including those that caused SARS, MERS, and Covid-19. Early trials involving a small group showed a modest effect on immune systems.

The Economic Times

RFK Jr. Wants to Access Medical Data of All Americans To Study Vaccines And Autism Links

Robert F. Kennedy Jr. seeks access to Americans' medical records to explore vaccine-autism links, sparking privacy and data use concerns.

International Business Times UK

AI Designs Vaccine That Targets Multiple Viruses to Help Stop Future Outbreaks, And It's Already Been Tested

Researchers used AI to create a vaccine targeting multiple viruses, a breakthrough that could speed vaccine development and boost outbreak preparedness.

International Business Times UK

Ebola: vaccines alone won’t stop an outbreak – here’s what else is needed

Tensions have recently emerged around the Ebola response in eastern Democratic Republic of the Congo (DRC). These tensions have manifested in a series of incidents, including the burning of an Ebola treatment facility in Mongbwalu, confrontations involving families seeking to reclaim the bodies of relatives who had died from the…

The Conversation

World's first AI-designed vaccine developed by UK scientists enters human trials

A groundbreaking AI-designed vaccine for Crimean-Congo haemorrhagic fever has entered human trials, marking a world-first for medical research. Developed by Oxford University and Basecamp Research, this initiative showcases AI's potential to drastically accelerate vaccine development for emerging infectious diseases. The trial aims to assess safety and immune response, potentially ushering…

The Times of India

Get all your
news in one place.

100's of premium titles.
One news app.

Euronews

New AI-designed ‘universal vaccine’ could future-proof humans against unknown viruses

A new AI-designed vaccine capable of protecting against entire families of viruses could transform how the world prepares for a future pandemic.

MarketBeat

Arcturus Therapeutics Highlights mRNA Pipeline, CF Data and Vaccine Expansion at Jefferies

Arcturus Therapeutics (NASDAQ:ARCT) President and CEO Joseph Payne outlined the company’s messenger RNA programs, vaccine approvals and upcoming clinical milestones during a presentation at the Jefferies Global Healthcare Conference in New York. Payne described Arcturus as a “next generation messen

International Business Times UK

Doctors Testify at Senate Hearing: Possible Links Between COVID Injections and Cancer

A US Senate subcommittee hearing examined potential links between COVID-19 vaccines and aggressive cancers, with experts presenting conflicting views on causation and the need for further research

Euronews

Tech giants warn AI safety gaps could hand bioweapons to bad actors

Synthetic DNA can be used for vaccines, but it can also create bioweapons. Tech giants and biotechnology experts are asking for stronger regulation.

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK

Scientists develop vaccine using AI that could prevent future pandemics

IN FULL

Evening Standard

New AI-designed vaccine ‘could protect against whole families of viruses’

An early trial of a vaccine made using the technology found it is safe and well-tolerated, with a larger study to include more than 200 people.

The Independent UK

AI ‘super-antigen’ vaccine could protect against whole families of viruses

Researchers say this could prevent future pandemics, save lives and stop lockdowns

Saving Advice

6 Reasons Adults Over 60 Should Ask About the RSV Vaccine

RSV sends more than 180,000 seniors to the hospital every year. Despite that, many people 75 and older remain unvaccinated against the virus. Respiratory syncytial...

The Conversation

Three new Ebola vaccines are being developed. An infectious disease expert explains

When it comes to Ebola outbreaks, it’s not often we have two pieces of good news in one week.

The Conversation

Two scientists on their race to make a new Ebola vaccine

As health workers in the Democratic Republic of Congo (DRC) continue to battle an ongoing Ebola outbreak, scientists around the world are racing to develop a vaccine against the strain of the virus that’s causing it.

The Guardian - UK

The race to combat Ebola: what vaccines and treatments are being developed and how long will it take?

With the Bundibugyo strain of the disease spreading across the DRC and Uganda, scientists and researchers are trying to find rapid solutions

1 … 3 4 5 6

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

University of Cambridge

223 stories

the University of Cambridge

209 stories

the University of Oxford

175 stories

The Conversation Weekly

142 stories

American Cancer Society

58 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Artificial Intelligence

Places

the Democratic Republic of Congo

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.